Trial Profile
Intravenous Exenatide Infusion in Critically Ill Patients With Acute Brain Injury
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Hyperglycaemia
- Focus Therapeutic Use
- 14 Sep 2017 Status changed from recruiting to completed.
- 11 May 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 11 May 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.